Drug intelligence / Profile preview

Shensu Pills

Development stage: Unknown
Lead developer: Shaanxi Ziguang Chenji Pharmaceutical
Administration: Oral

Overview

Shensu Pills is a traditional Chinese medicine (TCM) product developed and manufactured by Jiangsu Tiansheng Pharmaceutical. It is an oral medication available in both water-based (水丸) and honey-based (蜜丸) pill formulations. The drug is indicated for the treatment of the common cold, cough, and fever, particularly in individuals with qi deficiency. Its therapeutic actions include replenishing qi, resolving phlegm, and relieving exterior symptoms. It is currently approved for use in China.

Brand names: Shensu Pills
Other names: 参苏丸Shensu WanShensu Pills (water-based)Shensu Pills (honey-based)

Beyond the preview

Go deeper on Shensu Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shensu Pills.

Explore the full profile